Discovery of Potent Benzoselenazinone-Based DprE1 Inhibitors: A Novel Selenium-Containing Scaffold with Superior Anti-TB Activity and Pharmacokinetic Properties.

macozinone (PBTZ169) - Innovative Medicines for Tuberculosis, Nearmedic, Bill & Melinda Gates Foundation

http://www.ncbi.nlm.nih.gov/pubmed/41996283

Andrea Tresoldi; Baolian Wang; Bin Wang; Chengxia Mao; Haihong Huang; Laurent R Chiarelli; Mario Cocorullo; Matteo Mori; Peng Li; Xiuli Xu; Yang Liu; Yu Lu

Apr 19, 2026